Ticovac Junior

Ticovac Junior is an inactivated vaccine for tick-borne encephalitis (TBE) prevention in children and adolescents. This EU-approved immunization helps protect against TBE virus exposure through tick bites. Ideal for travel or outdoor activities in endemic regions. Short version: pediatric TBE vaccine for tick bite prevention.

Ticovac Junior is used to help prevent tick-borne encephalitis (TBE) in children and adolescents aged 1 to 15 years. It is designed for individuals at risk of exposure to TBE virus through tick bites, such as those living in or traveling to endemic areas. The vaccine stimulates the immune system to produce antibodies against the TBE virus. Parents often ask, 'What is Ticovac Junior used for?' to protect their children during outdoor activities.

After vaccination with Ticovac Junior, the body begins building immunity against the tick-borne encephalitis virus. Most recipients experience mild, temporary effects such as soreness at the injection site or mild fever. These are normal signs the immune system is responding. Some may feel tired or experience mild headache following the shot.

Ticovac Junior should be handled and administered by a healthcare professional. Inform the provider if the recipient has a fever or severe infection before vaccination. Keep the vaccine refrigerated and protect it from light until use. Do not freeze. After administration, monitor for any unusual reactions and report concerns to a healthcare provider promptly.

Ticovac Junior may be given with other vaccines, but separate injection sites should be used. Immunosuppressive therapies or corticosteroids may reduce vaccine effectiveness. Always inform your healthcare provider about any medications or treatments being used. Blood products or immune globulins should not be given close to vaccination without medical advice.